Hormone Therapy Said to Increase Risk of Ovarian Cancer – Were Bio Identicals Considered?

One more study on hormone replacement therapy, and in reading the information here, there’s no mention of whether or not bio identicals were included in the study, something we would all like to have some information about. Not too long ago I interviewed Dr. Erika Schwartz and this is one of the hot topics discussed…where are the studies on bio identical replacements. Were the studies based on Prempro and Premarin the combined estrogen-progestin therapy sold by Wyeth which are made from horses urine, or were other resources such as bio identical replacements considered? You can read more about Dr. Erika and her comments and knowledge on the subject at the link below. BD

Bioidentical Hormone Replacement Therapy– Interview with Dr. Erika Schwartz

CHICAGO (Reuters) — Women who took hormone replacement therapy after menopause had a sharply increased risk of ovarian cancer, researchers in Denmark are reporting.

In a study of more than 900,000 Danish women ages 50 to 79, the scientists found 140 extra cases of ovarian cancer linked to hormone treatment over eight years. That translated to a 38 percent greater risk of contracting the disease, compared with women who did not receive the therapy.

The findings were similar to those in the 2002 Women’s Health Initiative study, which was stopped early because it found an increased risk of ovarian cancer, breast cancer, strokes and other health problems from hormone therapy.

Hormone Therapy Said to Increase Risk of Ovarian Cancer - NYTimes.com